The Unitary Patent and the Unified Patent Court will significantly impact the patent system in Europe. For applicants or owners of European patents, it is time to inventory your IP portfolio and strategise whether your patents are more suited to the classic European system or the upcoming Unitary Patent system.

Niklas Mattsson and Louise Jonshammar from AWA’s Stockholm office will guide you through the advantages and pitfalls of the Unitary Patent system during this webinar. The duo will introduce how the system exposes your portfolio to risks, while also opening it up to offensive possibilities against infringers.

With this change expected towards the end of 2022 or in early 2023 – do not miss the opportunity to learn about the unitary package and raise your questions to Niklas and Louise during our dedicated Q&A session at the end of the webinar.

Please click here to register

Panelists:

Niklas Mattsson – European Patent Attorney, Partner

Niklas specialises in life sciences, with extensive experience in drafting and prosecuting patents and providing IP-related business advice. Niklas conducts infringement, validity and freedom-to-operate analyses and also has expertise in Supplementary Protection Certificates (SPCs) in the EU.

Niklas works as a technical expert during litigation cases before Swedish courts, handles EPO oral proceedings and has been an expert witness on European patent law in US patent litigation. He has been the Swedish representative in epi’s Biotech Committee since 2011 and a member of AIPPI’s Standing Committee on Pharma and Biotechnology since 2016. He is a graduate from CEIPI’s diploma course on European patent litigation and will thus be entitled to act in the new court as a European patent attorney.

Louise Jonshammar – Senior Attorney at Law

Louise has extensive experience in Swedish and European patent law and regulations with a specialisation in Supplementary Protection Certificates. She strategically assists clients to manage their inventions by ensuring that value is maintained and maximised, securing and sustaining a competitive advantage for them in increasingly crowded markets.

Her clients range from pharmaceutical giants to promising IP-rich start-ups, with a focus on turning research results into profitable intellectual assets. She has worked with clients of all sizes across a range of industries to manage their intellectual property rights. This includes through licensing and transfer, and to develop IP strategies and internal processes that align with a company’s business plan.